Your browser doesn't support javascript.
loading
Bone marrow transplantation for Diamond-Blackfan anemia.
Mugishima, H; Gale, R P; Rowlings, P A; Horowitz, M M; Marmont, A M; McCann, S R; Sobocinski, K A; Bortin, M M.
Afiliação
  • Mugishima H; International Bone Marrow Transplant Registry, Health Policy Institute, Medical College of Wisconsin, Milwaukee 53226, USA.
Bone Marrow Transplant ; 15(1): 55-8, 1995 Jan.
Article em En | MEDLINE | ID: mdl-7742755
ABSTRACT
Diamond-Blackfan anemia (DBA) is a rare disorder usually diagnosed in the first year of life. Although most cases respond to corticosteroids, > 20% are, or become, steroid-resistant. We report 10 children with DBA who received a bone marrow transplant from an HLA-identical sibling (n = 8), maternal (n = 1) or unrelated (n = 1) donor and reported to the International Bone Marrow Transplant Registry. Among eight recipients of HLA-identical sibling transplants, six are alive 5-87 months after transplant with no evidence of DBA and with Karnofsky performance scores of 90-100%. The two recipients of non-HLA-identical sibling transplants died < 2 weeks after transplant. The actuarial 2-year probability of survival for the eight sibling transplants was 72 (37-92)% (95% confidence interval).
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Anemia de Fanconi Idioma: En Ano de publicação: 1995 Tipo de documento: Article País de afiliação: Estados Unidos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Anemia de Fanconi Idioma: En Ano de publicação: 1995 Tipo de documento: Article País de afiliação: Estados Unidos